ATOSSA THERAPEUTICS, INC. Restricted Cash and Cash Equivalents
ATOSSA THERAPEUTICS, INC. (ATOS) had Restricted Cash and Cash Equivalents of $110.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-07
- 2026-06-30: Restricted Cash and Cash Equivalents $110.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents $110.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents $110.00K.
- 2025-09-30: Restricted Cash and Cash Equivalents $110.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2026-06-30 | $110.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $110.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $110.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $110.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $110.00K 10-Q · filed 2026-08-07 |
| 2025-03-31 | $110.00K 10-Q · filed 2026-05-08 |
| 2024-12-31 | $110.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $110.00K 10-Q · filed 2025-11-12 |
| 2024-06-30 | $110.00K 10-Q · filed 2025-08-12 |
| 2024-03-31 | $110.00K 10-Q · filed 2025-05-13 |
| 2023-12-31 | $110.00K 10-K · filed 2025-03-25 |
| 2023-09-30 | $110.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $110.00K 10-Q · filed 2024-08-12 |
| 2023-03-31 | $110.00K 10-Q · filed 2024-05-13 |
| 2022-12-31 | $110.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $110.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | $110.00K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $110.00K 10-Q · filed 2023-05-15 |
| 2021-12-31 | $110.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $110.00K 10-Q · filed 2022-11-07 |
| 2021-06-30 | $110.00K 10-Q · filed 2022-08-08 |
| 2021-03-31 | $110.00K 10-Q · filed 2022-05-09 |
| 2020-12-31 | $110.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $110.00K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $110.00K 10-Q · filed 2021-08-13 |
| 2020-03-31 | $110.00K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $110.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $110.00K 10-Q · filed 2020-11-13 |
| 2019-06-30 | $110.00K 10-Q · filed 2020-08-13 |
| 2019-03-31 | $110.00K 10-Q · filed 2020-05-13 |
| 2018-12-31 | $110.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $55.00K 10-Q · filed 2019-11-13 |
| 2018-06-30 | $55.00K 10-Q · filed 2019-08-13 |
| 2018-03-31 | $55.00K 10-Q · filed 2019-05-13 |
| 2017-12-31 | $55.00K 10-K · filed 2019-03-28 |
| 2017-09-30 | $55.00K 10-Q · filed 2018-11-14 |
| 2016-12-31 | $55.00K 10-K/A · filed 2017-03-21 |
| 2016-09-30 | $55.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $55.00K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $275.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $275.00K 10-K/A · filed 2017-03-21 |
| 2015-09-30 | $275.00K 10-Q · filed 2015-11-12 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |